Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Active Trading Environment
Glenmark Pharmaceuticals Ltd. has seen a notable rise in open interest, reaching 28,741 contracts, alongside a trading volume of 35,024 contracts. The stock outperformed its sector and hit an intraday high, although investor participation has declined significantly. The trading environment remains active, reflecting current market trends.
Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting notable activity in the stock. The latest open interest stands at 28,741 contracts, up from the previous figure of 25,021, marking a change of 3,720 contracts or a 14.87% increase. The trading volume for the day reached 35,024 contracts, indicating robust market engagement.In terms of price performance, Glenmark Pharmaceuticals outperformed its sector by 2.9%, with the stock hitting an intraday high of Rs 2,006, representing a gain of 4.54%. The stock's current price is above the 5-day, 50-day, 100-day, and 200-day moving averages, although it remains below the 20-day moving average.
Despite this positive price movement, there has been a decline in investor participation, with delivery volume dropping by 56.8% compared to the 5-day average. The stock maintains adequate liquidity, with a trading capacity of Rs 2.01 crore based on 2% of the 5-day average traded value.
Overall, the increase in open interest alongside the stock's performance metrics highlights a dynamic trading environment for Glenmark Pharmaceuticals, reflecting underlying market trends without indicating future movements.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Activity
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Most Read
